Kenvue Inc (KVUE) - Return on Sales by Net Profit

Kenvue Inc - graphic logo of issuer KVUE

Kenvue Inc. dominates the consumer health segment by developing scientific formulas and digital care. The net realization margin demonstrates stability, with the current level standing at 10.90, which helps avoid purchasing overvalued stocks. An efficient warehouse network eliminates product shortages, although geopolitics and inflation create risks of asset write-downs and consumers switching to cheaper alternatives.

KVUE: Kenvue Health Net Sales Margin 02/21/2024 - 11/14/2026

Kenvue Corp (KVUE) - metric breakdowns and financial figures

- market value and analyst target forecast:
- market capitalization indicators:
Analysis of all company metrics:Kenvue Inc.
Finished products of Kenvue Inc

To minimize investment risks, Kenvue Inc. (KVUE) must filter out market noise by evaluating cost management efficiency through the share of net profit in every dollar of revenue. Analyzing the net profit margin trend on GURU.Markets, an investor will see how the dominance of the Tylenol and Listerine brands allows the company to pass inflation onto consumers, ensuring high operational resilience and fundamental business reliability.

Key competitors

HLN: Net Sales Margin|Verona Pharma PLC - Net Profit Rate|Net Margin Jyong Biotech Ltd|Net Sales Margin Ligand Corp|Net Sales Margin AMRX|Company Sales Margin Perrigo Company plc|Net Sales Margin ALVO (Alvotech Biopharmaceuticals)|LQDA: Net Return on Sales|Galapagos N.V. - Net Sales Margin|ANIP - Net Sales Margin|MNKD: Net Sales Margin|amphastar.com (AMPH) - Net Sales Margin|PCRX (Pacira Pharmaceuticals) - Net Sales Margin|Return on Sales by Net Profit ARS Pharmaceuticals, Inc. (SPRY)|Net Sales Margin TBPH|AQST (Aquestive Therapeutics) - Net Profit Rate|scPharmaceuticals, Inc. - Return on Sales by Net Profit|Net Profit Rate TECX|tonixpharma.com - Net Sales Margin|Net Profit Rate SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Net Margin|Return on Sales by Net Profit BioHarvest|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma